These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Letter: Linoleic acid as an immunosuppressive agent. Weyman C; Belin J; Smith AD; Thompson RH Lancet; 1975 Jul; 2(7923):33. PubMed ID: 49625 [No Abstract] [Full Text] [Related]
5. Non-specificity of laboratory test for diagnosis of multiple sclerosis. Mertin J; Hughes D; Caspary EA; Thomson AM; Foster JB; Stewart-Wynne EG Br Med J; 1974 Dec; 4(5944):567-9. PubMed ID: 4434141 [TBL] [Abstract][Full Text] [Related]
6. Genetical factors in the aetiology of multiple sclerosis. Berry RJ Acta Neurol Scand; 1969; 45(4):459-83. PubMed ID: 5817381 [No Abstract] [Full Text] [Related]
7. [The effect of bleomycin on PHA-stimulated lymphocytes in vitro]. Lutz D; Grohs H; Haist B; Stacher A Int J Clin Pharmacol; 1974 Mar; 9(2):146-53. PubMed ID: 4133293 [No Abstract] [Full Text] [Related]
8. Letter: Effect of prednisolone on lymphocyte transformation in multiple sclerosis. Biggins JA; Caspary EA Lancet; 1975 Mar; 1(7908):686. PubMed ID: 47112 [No Abstract] [Full Text] [Related]
9. Letter: Unsaturated fatty acids and cellular immunity. Field EJ Lancet; 1975 Nov; 2(7941):934. PubMed ID: 53422 [No Abstract] [Full Text] [Related]
10. Letter: Inhibition of lymphocyte response to stimulants by unsaturated fatty acids and prostaglandins. Field EJ; Shenton BK Lancet; 1974 Sep; 2(7882):725. PubMed ID: 4142999 [No Abstract] [Full Text] [Related]
12. Letter: Diagnostic test for multiple sclerosis. Jenssen HL; Köhler H; Gunther J; Meyer-Rienecker H Br Med J; 1974 Nov; 4(5941):407. PubMed ID: 4425900 [No Abstract] [Full Text] [Related]
13. Lymphotoxic activity in multiple sclerosis serum. Van den Noort S; Stjernholm RL Neurology; 1971 Aug; 21(8):783-93. PubMed ID: 5106294 [No Abstract] [Full Text] [Related]
14. [Transformation of lymphocytes of patients with multiple sclerosis, after treatment in vitro with phytoagglutinins]. Becuş T; Gyargyay-Malatinski E; Kovács V Neurol Psihiatr Neurochir; 1973; 18(4):367-75. PubMed ID: 4356513 [No Abstract] [Full Text] [Related]
15. Letter: Linoleic acid in multiple sclerosis. Field EJ; Shenton BK Br Med J; 1975 Feb; 1(5955):456. PubMed ID: 1115975 [No Abstract] [Full Text] [Related]
16. [The in vitro influence of dehydrobenzperidol (droperidol) on lymphocyte transformation (author's transl)]. Cerni C; Lackner J; Lackner F Anaesthesist; 1975 Sep; 24(9):412-5. PubMed ID: 1190423 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte transformation induced in vitro by PHA and PPD in multiple sclerosis. Cendrowski W; Niedzielska K J Neurol Neurosurg Psychiatry; 1970 Feb; 33(1):92-4. PubMed ID: 5418184 [No Abstract] [Full Text] [Related]
18. Letter: Inhibition of lymphocyte response to stimulants induced by unsaturated fatty acids and prostaglandins in multiple sclerosis. Offner H; Clausen J Lancet; 1974 Nov; 2(7890):1204-5. PubMed ID: 4139616 [No Abstract] [Full Text] [Related]
19. [Plant agglutinin- and PPD tuberculin-stimulated lymphocyte transformation in vitro in patients with disseminated sclerosis]. Cendrowski W; Moskalewska K; Plonka T; Niedzielska K Neurol Neurochir Pol; 1971; 5(4):485-8. PubMed ID: 4330664 [No Abstract] [Full Text] [Related]
20. Relevance of fatty acids in multiple sclerosis. Mertin J; Meade CJ Br Med Bull; 1977 Jan; 33(1):67-71. PubMed ID: 318891 [No Abstract] [Full Text] [Related] [Next] [New Search]